AgFin Australia

Uncategorized

Stocks of the Hour: Chimeric Therapeutics, Armada, Site Group International, Linius Technologies

To register for Friday’s webinar click here. Chimeric Therapeutics (ASX:CHM) announced positive preclinical data for CHM 1301, the Company’s off-the-shelf cell therapy. The results show up to 300% enhanced cell killing demonstrated compared to first generation NK cells and there is evidence of expansion into two new solid tumours – pancreatic cancer and ovarian cancer.

Stocks of the Hour: Chimeric Therapeutics, Armada, Site Group International, Linius Technologies Read More »